Get informed when a big investor buys or sells
+ Follow69.21%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Ju Fu Tang Biotech Holdings , Ltd (8217.HK) currently reports a ROE of 69.21%. That is above the Industrials sector average of 35.64%. Use the charts on this page to explore Ju Fu Tang Biotech Holdings , Ltd's ROE history and peer comparisons.
Ju Fu Tang Biotech Holdings , Ltd's ROE of 69.21% is higher than the Industrials sector average of 35.64%. That is roughly 94.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Ju Fu Tang Biotech Holdings , Ltd's current 69.21% should be judged against Industrials norms (sector average: 35.64%) and against 8217.HK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 69.21%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 35.64%. From there, open related valuation or income-statement pages for Ju Fu Tang Biotech Holdings , Ltd, and consider following 8217.HK for alerts when major investors trade the stock.
Ju Fu Tang Biotech Holdings , Ltd is classified in the Industrials sector. On ROE, it currently shows 69.21% versus a sector average near 35.64%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing 8217.HK with unrelated industries.